Unexpected only pulmonary manifestation of sarcoidosis

• References

• 1 Aide N, Benayoun M, Kerrou K. et al. Impact of ¹⁸F-fluorodeoxyglucose imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by ¹⁸F-FDG PET and early metabolic response to corticosteroid therapy. Br J Radiol 2007; 80: e67-e71.
• 2 Basu S, Yadav M, Joshi JM. et al. Active pre-treatment pure pulmonary parenchymal sarcoidosis with raised serum angiotensin converting enzyme level: characteristics on PET with glucose metab- olism and cell proliferation tracers and HRCT. Eur J Nucl Med Mol Imaging. 2011
• 3 DeRemee RA. The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives. Chest 1983; 83: 128-133.
• 4 James D, Thompson A. The course of sarcoidosis and its modification by treatment. Lancet 1959; 1: 1057-1061.
• 5 Keijsers RG, Grutters JC, van Velzen-Blad H. et al. ¹⁸F-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis. Eur J Nucl Med Mol Imaging 2010; 37: 1181-1188.
• 6 Lannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357: 2153-2165.
• 7 Prager E, Wehrschuetz M, Bisail B. et al. Comparison of ¹⁸F-FDG and ⁶⁷Ga-citrate in sarcoidosis imaging. Nuklearmedizin 2008; 47: 18-23.
• 8 Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J 1961; 2: 1165-1172.
• 9 Teirstein AS, Machac J, Almeida O. et al. Results of 188 whole-body fluoro deoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007; 132: 1949-1953.
• 10 Xiu Y, Yu JQ, Cheng E. et al. Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy. Clin Nucl Med 2005; 30: 193-195.